Literature DB >> 8735412

Auditory nerve-brainstem responses in cystic fibrosis patients.

T Ozcelik1, N Ozgirgin, U Ozcelik, A Gocmen, B Gurcan, N Kiper.   

Abstract

We conducted a study in 30 children with cystic fibrosis (CF) to determine if their hearing had been affected. Their ages ranged between 2 to 17 years and they were studied by means of complete audiologic evaluation and brainstem evoked response audiometry (BERA). Twenty of them had received some ototoxic drugs for variable periods. The results showed that there was no significant correlation between CF and BERA findings. The findings indicated that, except a few middle ear problems such as serous otitis media, CF did not affect hearing status of the CF children per se.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8735412     DOI: 10.1016/0165-5876(95)01321-0

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  3 in total

1.  Interaction between CFTR and prestin (SLC26A5).

Authors:  Kazuaki Homma; Katharine K Miller; Charles T Anderson; Soma Sengupta; Guo-Guang Du; Salvador Aguiñaga; Maryann Cheatham; Peter Dallos; Jing Zheng
Journal:  Biochim Biophys Acta       Date:  2010-02-06

2.  Functional Impacts of Aminoglycoside Treatment on Speech Perception and Extended High-Frequency Hearing Loss in a Pediatric Cystic Fibrosis Cohort.

Authors:  Chelsea M Blankenship; Lisa L Hunter; M Patrick Feeney; Madison Cox; Lindsey Bittinger; Angela C Garinis; Li Lin; Gary McPhail; John P Clancy
Journal:  Am J Audiol       Date:  2021-01-19       Impact factor: 1.636

3.  Does amikacin treatment cause subclinical hearing loss in patients with cystic fibrosis?

Authors:  Fevzi Solmaz; Ercan Gündoğdu; Davut Akduman; Mehmet Haksever; Oğuzhan Dikici; Fatih Ünal
Journal:  Toxicol Rep       Date:  2016-03-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.